Cargando…
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis
BACKGROUND & AIMS: Advanced hepatic fibrosis is the main risk factor of liver-related morbidity and mortality in patients with chronic liver disease. In this study, we assessed the potential role of bone morphogenetic protein 8A (BMP8A) as a novel target involved in liver fibrosis progression. M...
Autores principales: | Marañón, Patricia, Isaza, Stephania C., Fernández-García, Carlos Ernesto, Rey, Esther, Gallego-Durán, Rocío, Montero-Vallejo, Rocío, de Cía, Javier Rodríguez, Ampuero, Javier, Valverde, Ángela M., Romero-Gómez, Manuel, García-Monzón, Carmelo, González-Rodríguez, Águeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142503/ https://www.ncbi.nlm.nih.gov/pubmed/37106416 http://dx.doi.org/10.1186/s40364-023-00489-2 |
Ejemplares similares
-
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
por: Marañón, Patricia, et al.
Publicado: (2022) -
Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
por: Rey, Esther, et al.
Publicado: (2021) -
Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea
por: Rey, Esther, et al.
Publicado: (2020) -
Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36
por: Rey, Esther, et al.
Publicado: (2020) -
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Gallego-Durán, Rocío, et al.
Publicado: (2021)